Replies to post #714089 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Or, if DCVax-l approved, some company like a Regeneron would go all in on NWBO and make it worth everyone’s while. Some structure culminating in….

It’s a company ripe for buyout.
1. Strong Science.
2. Combo patents, Direct Patents, other patent applications (hyperactive DC) and patents associated with company it absorbed.
3. Very advanced automated closed system manufacturing, with loads of patents.
4. Universal cancer vaccine technology refined over the years.
5. Old management.

I know most BP don’t want to eventually cure anything, but some medium sized ones do.

[Horseb4CarT]

Are you taking into account that revenues at something like 150,000-200,000 pounds per patient will start after approval?

Also, combination trials and licensed trials and licensing of the dendritic cell technology and potentially even Eden automated closed system production technology fees!

Approval will mark the new beginning!!

[theorysuit]

4 years since data lock and no regulatory submissions outside UK (and that too without any clarity on when reimbursement submissions will be made in the UK) tells you everything you need to know.

This 100%. How can this level of slow execution even be possible? I will tell you. LP mission was first and foremost to line her pockets. COGNATE COGNATE COGNATE. THEN. ADENT ADENT ADVENT. AND ALL THE WHILE, SALARY SALARY SALARY AND AWARD AWARD AWARD.

Simple. Distract everyone with external excuses and the story that everyone is against NWBO in this david vs Goliath BS sob story.